We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+336.66%
AUM
$405B
AUM Growth
+$3.26B
Cap. Flow
-$4.73B
Cap. Flow %
-1.17%
Top 10 Hldgs %
17.59%
Holding
10,501
New
1,227
Increased
3,693
Reduced
4,131
Closed
1,043

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.12B
2
AAPL icon
Apple
AAPL
+$1.08B
3
MSFT icon
Microsoft
MSFT
+$1.05B
4
NKE icon
Nike
NKE
+$1.03B
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$821M

Sector Composition

Rank Sector Weight
1 Technology 17.8%
2 Financials 8.25%
3 Healthcare 6.4%
4 Consumer Discretionary 5.85%
5 Communication Services 4.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NJUN
8326
Innovator Growth-100 Power Buffer ETF - June
NJUN
$171M
$2.48K ﹤0.01%
+96
New +$2.46K
LONA
8327
LeonaBio Inc
LONA
$70.2M
$2.47K ﹤0.01%
93
SQEW
8328
DELISTED
LeaderShares Equity Skew ETF
SQEW
$2.47K ﹤0.01%
+75
New +$2.42K
IMDX
8329
Insight Molecular Diagnostics
IMDX
$162M
$2.46K ﹤0.01%
835
-29
-3% -$80
DRUP icon
8330
GraniteShares Nasdaq Select Disruptors ETF
DRUP
$49.8M
$2.46K ﹤0.01%
46
-192
-81% -$9.61K
MSAI icon
8331
MultiSensor AI
MSAI
$10.3M
$2.45K ﹤0.01%
37
-17
-31% -$1.67K
QRMI icon
8332
Global X NASDAQ 100 Risk Managed Income ETF
QRMI
$15.6M
$2.44K ﹤0.01%
+145
New +$2.47K
INOV icon
8333
Innovator International Developed Power Buffer ETF November
INOV
$37.4M
$2.44K ﹤0.01%
86
PXDT
8334
DELISTED
Pixie Dust Technologies, Inc. American Depositary Shares
PXDT
$2.44K ﹤0.01%
+1,605
New +$3.67K
YEAR icon
8335
AB Ultra Short Income ETF
YEAR
$1.51B
$2.42K ﹤0.01%
+48
New +$2.42K
BDL icon
8336
Flanigan's Enterprises
BDL
$82.9M
$2.42K ﹤0.01%
90
BCLI
8337
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$2.41K ﹤0.01%
474
+307
+184% +$2.3K
VSMV icon
8338
VictoryShares US Multi-Factor Minimum Volatility ETF
VSMV
$155M
$2.41K ﹤0.01%
53
-64
-55% -$2.84K
MCAG
8339
DELISTED
Mountain Crest Acquisition Corp. V Common Stock
MCAG
$2.4K ﹤0.01%
220
+153
+228% +$1.65K
PBJN
8340
PGIM US Large-Cap Buffer 20 ETF - June
PBJN
$55.4M
$2.39K ﹤0.01%
+94
New +$2.38K
MNTL
8341
DELISTED
Tema Neuroscience and Mental Health ETF
MNTL
$2.39K ﹤0.01%
+93
New +$2.31K
ISZE
8342
DELISTED
iShares MSCI Intl Size Factor ETF
ISZE
$2.38K ﹤0.01%
92
QPX icon
8343
AdvisorShares Q Dynamic Growth ETF
QPX
$31.5M
$2.37K ﹤0.01%
70
-970
-93% -$31.5K
BIRD icon
8344
Smartbird Inc
BIRD
$19.8M
$2.37K ﹤0.01%
237
-4,725
-95% -$57.7K
SPWR icon
8345
SunPower Inc
SPWR
$60.9M
$2.37K ﹤0.01%
2,114
+1,877
+792% +$1.85K
ATXI
8346
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
$2.36K ﹤0.01%
+673
New +$3.91K
CLDL
8347
DELISTED
Direxion Daily Cloud Computing Bull 2X Shares
CLDL
$2.35K ﹤0.01%
245
-717
-75% -$6.9K
ACGR
8348
American Century Large Cap Growth ETF
ACGR
$10.4M
$2.35K ﹤0.01%
+43
New +$2.21K
NFLY icon
8349
YieldMax NFLX Option Income Strategy ETF
NFLY
$38.4M
$2.35K ﹤0.01%
134
-2,539
-95% -$44.3K
IGLD icon
8350
FT Vest Gold Strategy Target Income ETF
IGLD
$502M
$2.34K ﹤0.01%
+117
New +$2.35K

Similar funds

UBS Group's Q2 2024 Portfolio in Review

As of Q2 2024, UBS Group held 10,501 positions worth $405B, up 0.81% from $402B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

UBS Group's Q2 2024 filing shows 1,227 new, 3,693 increased, 4,131 reduced and 1,043 closed positions. Its largest new stake was SLB Ltd: 10,925,731 shares worth $515M. The largest sale was BioMarin Pharmaceuticals, an estimated $389M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Financials and Healthcare.

  • UBS Group's largest Q2 2024 buy was SLB Ltd: 10,925,731 shares worth $515M.
  • UBS Group added most to NVIDIA in Q2 2024, an estimated $1.12B increase.
  • UBS Group's biggest Q2 2024 reduction was BioMarin Pharmaceuticals, cutting an estimated $389M.
  • UBS Group fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $263M.
  • UBS Group's ten largest holdings make up 18% of its $405B portfolio in Q2 2024.
  • UBS Group opened 1,227 new positions and closed 1,043 in Q2 2024.
  • UBS Group's portfolio value rose 0.81% quarter-over-quarter to $405B.

Based on UBS Group's 13F filing for Q2 2024, filed 14 Aug 2024.